title: BiP, an endoplasmic reticulum chaperone, modulates the development of morphine antinociceptive tolerance.
abstract: Morphine is a potent analgesic, but the molecular mechanism for tolerance formation after repeated use is not fully understood. Binding immunoglobulin protein (BiP) is an endoplasmic reticulum (ER) chaperone that is central to ER function. We examined knock-in mice expressing a mutant BiP with the retrieval sequence deleted in order to elucidate physiological processes that are sensitive to BiP functions. We tested the thermal antinociceptive effect of morphine in heterozygous mutant BiP mice in a hot plate test. Paw withdrawal latencies before and after a single administration of morphine were not significantly different between the wild-type and mutant BiP mice. Repeated morphine administration caused the development of morphine tolerance in the wild-type mice. The activation of glycogen synthase kinase 3b (GSK-3b) was associated with morphine tolerance, because an inhibitor of GSK-3β prevented it. On the other hand, the mutant BiP mice showed less morphine tolerance, and the activation of GSK-3b was suppressed in their brain. These results suggest that BiP may play an important role in the development of morphine tolerance. Furthermore, we found that a chemical chaperone which improves ER protein folding capacity also attenuated the development of morphine tolerance in wild-type mice, suggesting a possible clinical application of chemical chaperones in preventing morphine tolerance.
authors.affiliation: Department of Anesthesiology, Chiba University Graduate School of Medicine, Chiba, Japan.
authors.forename: Tamae
authors.initials: T
authors.lastname: Dobashi
authors.forename: Serabi
authors.initials: S
authors.lastname: Tanabe
authors.forename: Hisayo
authors.initials: H
authors.lastname: Jin
authors.forename: Naoya
authors.initials: N
authors.lastname: Mimura
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Nishino
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Aoe
mesh_terms: D000700:Analgesics / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D015153:Blotting, Western; D004361:Drug Tolerance; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D000091342:Endoplasmic Reticulum Chaperone BiP; D005455:Fluorescent Antibody Technique; D055879:Gene Knock-In Techniques; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006360:Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008817:Mice, Mutant Strains / Q000378:metabolism; D009020:Morphine / Q000008:administration & dosage; D058539:Phosphatidylinositol 3-Kinase / Q000378:metabolism*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D017450:Receptors, Opioid, mu / Q000037:antagonists & inhibitors; D017384:Sequence Deletion; D015398:Signal Transduction
chemical_list: D000700:Analgesics; D000091342:Endoplasmic Reticulum Chaperone BiP; D006360:Heat-Shock Proteins; D000081082:Phosphoinositide-3 Kinase Inhibitors; D017450:Receptors, Opioid, mu; D009020:Morphine; D058539:Phosphatidylinositol 3-Kinase; D000071679:Glycogen Synthase Kinase 3 beta; C000605507:Gsk3b protein, mouse; D038362:Glycogen Synthase Kinase 3